Your browser doesn't support javascript.
loading
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.
Wing, Peter A C; Schmidt, Nathalie M; Peters, Rory; Erdmann, Maximilian; Brown, Rachel; Wang, Hao; Swadling, Leo; Newman, Joseph; Thakur, Nazia; Shionoya, Kaho; Morgan, Sophie B; Hinks, Timothy Sc; Watashi, Koichi; Bailey, Dalan; Hansen, Scott B; Davidson, Andrew D; Maini, Mala K; McKeating, Jane A.
Afiliación
  • Wing PAC; Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, United Kingdom.
  • Schmidt NM; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Peters R; Division of Infection and Immunity and Institute of Immunity and Transplantation, UCL, London, United Kingdom.
  • Erdmann M; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Brown R; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Wang H; Division of Infection and Immunity and Institute of Immunity and Transplantation, UCL, London, United Kingdom.
  • Swadling L; UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Newman J; Skaggs Graduate School of Chemical and Biological Sciences, The Scripps Research Institute, San Diego, California, United States of America.
  • Thakur N; Division of Infection and Immunity and Institute of Immunity and Transplantation, UCL, London, United Kingdom.
  • Morgan SB; The Pirbright Institute, Woking, United Kingdom.
  • Hinks TS; The Pirbright Institute, Woking, United Kingdom.
  • Watashi K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Bailey D; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.
  • Hansen SB; Research Centre for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Davidson AD; Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, Nuffield Department of Medicine, Experimental Medicine, University of Oxford, Oxford, United Kingdom.
  • Maini MK; Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, Nuffield Department of Medicine, Experimental Medicine, University of Oxford, Oxford, United Kingdom.
  • McKeating JA; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
PLoS Pathog ; 19(5): e1011323, 2023 05.
Article en En | MEDLINE | ID: mdl-37134108
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / COVID-19 Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / COVID-19 Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido